Systemic Immune Response in Murine Bilateral Pheochromocytoma Model During Immunotherapy Based on a Combination of Mannan-BAM, TLR Ligands and Anti-CD40 Antibodies (MBTA Therapy)

Immunotherapy has become an essential component of cancer treatment, however, a majority of patients with solid metastatic cancers, such as pheochromocytoma (PHEO), do not respond to this type of therapy. Recently, we developed an intratumoral (i.t.) immunotherapy based on the unique combination of...

Descripción completa

Detalles Bibliográficos
Autores principales: Uher, Ondrej, Huynh, Thanh-Truc, Zhu, Boqun, Horn, Lucas A, Medina, Rogelio, Wang, Herui, Palena, Claudia, Chmelar, Jindrich, Zhuang, Zhengping, Zenka, Jan, Pacak, Karel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Tumor Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089186/
http://dx.doi.org/10.1210/jendso/bvab048.2113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089186/
http://dx.doi.org/10.1210/jendso/bvab048.2113

Ejemplares similares